Cargando…

SAT-519 Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture Representative of Covered Commercial Insurance Enrollees

Abaloparatide (ABL) is a novel, selective activator of the PTH1 receptor signaling pathway. In the 18-month Phase 3 ACTIVE study in women with postmenopausal osteoporosis (NCT01343004), ABL significantly increased bone mineral density (BMD), and decreased the risk of vertebral (VF), nonvertebral (NV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saag, Kenneth, Williams, Setareh, Wang, Yamei, Weiss, Richard, Cauley, Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552091/ http://dx.doi.org/10.1210/js.2019-SAT-519

Ejemplares similares

OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019)

SUN-385 Differential Effects of Abaloparatide and Teriparatide on Hip Cortical Volumetric BMD by DXA-Based 3d Modeling
por: Winzenrieth, Renaud, et al.
Publicado: (2020)

SAT-540 Bisphosphonates and Fracture Incidence in Young Adults
por: Choudhary, Manita, et al.
Publicado: (2019)

SAT-509 Denosumab Use in Tertiary Hiperparathyroidism with Fracture
por: Coy, Andres, et al.
Publicado: (2019)

SAT-528 BMI and Relationship to Prior Fracture in the Super Obese
por: Iwamaye, Amy, et al.
Publicado: (2019)

SAT-515 Racial-Ethnic Differences in Diabetes-Related Fracture Risk
por: Jain, Rajesh, et al.
Publicado: (2019)

SUN-335 Abaloparatide Prevents Unloading-Induced Bone Loss in Adult Rats
por: Teguh, Dian A, et al.
Publicado: (2020)

SAT-524 Re-hospitalization And Mortality Outcome Following Atypical Femur Fracture
por: Yang, Betsy, et al.
Publicado: (2019)

SAT232 Patients With Chronic Hypoparathyroidism Have Higher Risk Of Vertebral Fracture And Lower Risk Of Femoral Fracture Compared To Controls
por: Bjornsdottir, Sigridur, et al.
Publicado: (2023)

SAT-534 How Has Bisphosphonate Prescribing Changed in the Past Decade for Primary Fracture?
por: Yang, Betsy, et al.
Publicado: (2019)

SAT-389 Clinical and Biochemical Characterization of Risk Factors for Vertebral Fractures in Patients with Hypoparathyroidism
por: Formenti, Anna Maria, et al.
Publicado: (2020)

SUN-519 Hypoparathyroidism after Harvoni Treatment for Hepatitis C
por: Sajja, Puspalatha, et al.
Publicado: (2019)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

SAT-522 Markers of Mineral Homeostasis and Bone Turnover in Patients Presenting with Acute Hip Fractures
por: Estrada, Kathleen, et al.
Publicado: (2019)

MON-365 Novel Use of Abaloparatide to Augment Spinal Fusion in Patient Undergoing Cervicothoracic Revision Surgery
por: Parikh, Sahil, et al.
Publicado: (2020)

OR13-05 Romosozumab Treatment Lowers the Incidence of New Vertebral Fractures Across All Fracture Severity Grades Among Postmenopausal Women with Osteoporosis
por: Feldman, Robert, et al.
Publicado: (2020)

PSAT156 Abaloparatide Implementation and Follow-Up: Real-World Results of a Pharmacist-Run Anabolic Osteoporosis Clinic
por: Arceri, Veronica, et al.
Publicado: (2022)

SAT-342 Humerus Fracture & Dislocation of Right Shoulder Following a Seizure in Non-Epileptic Patient Due to Hypoparathyroidism
por: Doub, Najah Younes, et al.
Publicado: (2020)

OR21-4 Comparison of the Effects of PTH (1-34), PTHrP (1-36) and Abaloparatide (ABL) on the Murine Osteoblast Transcriptome
por: He, Zhiming, et al.
Publicado: (2022)

Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
por: McClung, Michael R., et al.
Publicado: (2017)

SAT-LB089 Incorporation of a Patient Navigator into a Secondary Fracture Prevention Program Identifies Barriers to Patient Care
por: Jia, Kelly, et al.
Publicado: (2019)

SAT262 Bilateral Stress Fractures Of The Femur In A Patient With HIV On Long-term Tenofovir Disoproxil Fumarate And Short-term Alendronate
por: Mahatme, Ronak J, et al.
Publicado: (2023)

Correction to: Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
por: McClung, Michael R., et al.
Publicado: (2018)

MON-519 Impact of Chronic Hypoparathyroidism on Work, Productivity, and Relationships: Findings from a 13-Country Patient and Caregiver Survey
por: Clarke, Bart, et al.
Publicado: (2019)

SAT-535 Association Between Adiponectin and Bone Mineral Density in Mexican Postmenopausal Women with Normal Glucose Tolerance and Type 2 Diabetes Mellitus
por: Tenorio-Rojo, Andrea, et al.
Publicado: (2019)

FRI682 Cost Effectiveness Of Four Treatment Approaches For US Women And Men At Very High Risk Of Osteoporotic Fractures
por: Hiligsmann, Mickael, et al.
Publicado: (2023)

PSAT222 Muscle Weakness, Bone Pain, and Stress Fractures: When a Fracture is NOT JUST a Fracture: A Case Report
por: Rabiei, Samaneh, et al.
Publicado: (2022)

A Hospitalist-Led Fracture Liaison Service Improves Care of Hip Fracture Patients
por: Drabkin, Anne, et al.
Publicado: (2021)

ODP097 Hyperparathyroidism as a major risk factor of fracture and its prevalence in patients with hip fracture
por: Tan, Lok Yi Joyce, et al.
Publicado: (2022)

SAT-379 Giant Parathyroid Adenoma
por: Saberi, Sima, et al.
Publicado: (2020)

SAT-345 Etanercept Induced Hypercalcemia
por: Chaker, Bayan, et al.
Publicado: (2020)

SAT243 A Rare Triad
por: Liaqat, Hassan, et al.
Publicado: (2023)

SAT225 An Unexpected Case Of Hypocalcemia
por: Nogueira Cordeiro, Monica Fabiola, et al.
Publicado: (2023)

SAT189 Giant Parathyroid Adenoma
por: Shah, Siddharth, et al.
Publicado: (2023)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

SAT-497 Importance of OTC Medications in Hypercalcemia
por: Yedla, Niharika, et al.
Publicado: (2019)

SAT-366 Hypercalcemia Due to Castleman’s Disease
por: Khan, Sarah Adil, et al.
Publicado: (2020)

SAT-359 Hypercalcemia - Is This Sarcoidosis, Hyperparathyroidism, or Both?
por: Veeramachaneni, Ravali, et al.
Publicado: (2020)

SAT-398 The Use of Imaging in Primary Hyperparathyroidism
por: Broome, David Tyler, et al.
Publicado: (2020)

SAT-LB65 A Rare Existence
por: Bedia, Jiselle Aimee Yaplito, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u8utjr107agfes4qknaorqbiov